Rogers, Janyce F <br/><br/>
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.  [electronic resource] 

 -  The American journal of medicine  Dec 2002 
 - 746-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9343 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9343(02)01363-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Arrhythmia Agents--metabolism<br/>Antidepressive Agents, Tricyclic--metabolism<br/>Aryl Hydrocarbon Hydroxylases--metabolism<br/>Codeine--metabolism<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 CYP2D6--metabolism<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Diazepam--metabolism<br/>Genotype<br/>Glipizide--metabolism<br/>Humans<br/>Mixed Function Oxygenases--metabolism<br/>Omeprazole--metabolism<br/>Pharmacogenetics<br/>Phenotype<br/>Phenytoin--metabolism<br/>Warfarin--metabolism